Potential Cardioprotective Effects of Sumac Capsule in Patients With Hyperlipidemia: A Triple-Blind Randomized, Placebo-Controlled Crossover Trial.
Asgary S, Salehizadeh L, Keshvari M, Taheri M, Spence ND, Farvid MS, Rafieian-Kopaei M, Sarrafzadegan N.
Asgary S, et al. Among authors: rafieian kopaei m.
J Am Coll Nutr. 2018 May-Jun;37(4):286-292. doi: 10.1080/07315724.2017.1394237. Epub 2018 Feb 9.
J Am Coll Nutr. 2018.
PMID: 29425477
Clinical Trial.
RESULTS: Differences between placebo group and sumac group (placebo-sumac) were significantly decreased for BMI (0.21 0.075 kg/m(2)), SBP (1.87 0.83 mm Hg), DBP (1.32 0.46 mm Hg), and total cholesterol (14.42 4.95 mmol/L) and significantly increased for FMD (-0.23% 0.065%) …
RESULTS: Differences between placebo group and sumac group (placebo-sumac) were significantly decreased for BMI (0.21 0.075 kg/m(2)), …